Fintel reports that on January 7, 2025, Jefferies upgraded their outlook for Instil Bio (NasdaqCM:TIL) from Hold to Buy.

Fintel reports that on January 7, 2025, Jefferies upgraded their outlook for Royal Gold (NasdaqGS:RGLD) from Hold to Buy.

Jefferies analyst Daniel Fannon maintained a Buy rating on Goldman Sachs Group (GS – Research Report) today and set a price target of $667.00.

We recently published a list of Top 10 AI Stocks on Wall Street’s Radar. In this article, we are going to take a look at ...

Key stocks recommended by Jefferies for 2025 include Mankind Pharma, JB Chemicals, and Sun Pharmaceutical Industries.

Jefferies downgraded Blue Star Ltd. to 'hold' from 'buy' after the stock rallied 140% in calendar year 2024. The stock is now ...

Jefferies believes aggressive moves by incumbents and entry of new players in the QC space can result in higher discounting ...

Investing.com-- Jefferies downgraded Indian food delivery firm Zomato Ltd (NS: ZOMT) on Monday, stating that the stock was likely to see a year of consolidation after strong gains in 2024 due to ...

The global brokerage firm revised the target lower, citing increasing competition as a threat to the online food aggregator’s ...

Zomato receives positive outlook from analysts, maintaining "Overweight" rating with target price of 355, despite recent ...

After forming through the merger of three companies last summer, a Houston-based oil field services provider is going public.

China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.